Hepatitis Monthly

Published by: Kowsar

Association of Liver Enzymes with 10-year Cardiovascular Disease Risk: A Population-Based Study

Nima Motamed 1 , Behnam Rabiee 2 , Behzad Farahani 3 , Mahmood Reza Khonsari 2 , Zahedin Kheyri 4 , Gholam Reza Hemasi 2 , Mansooreh Maadi 2 and Farhad Zamani 2 , *
Authors Information
1 Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2 Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
3 Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran
4 Department of Medicine, Arak University of Medical Sciences, Arak, Iran
Article information
  • Hepatitis Monthly: January 01, 2017, 17 (1); e43901
  • Published Online: December 31, 2016
  • Article Type: Research Article
  • Received: November 12, 2016
  • Accepted: December 25, 2016
  • DOI: 10.5812/hepatmon.43901

To Cite: Motamed N, Rabiee B, Farahani B, Khonsari M R, Kheyri Z, et al. Association of Liver Enzymes with 10-year Cardiovascular Disease Risk: A Population-Based Study, Hepat Mon. 2017 ; 17(1):e43901. doi: 10.5812/hepatmon.43901.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Organization WH. The world health report 2002: reducing risks, promoting healthy life. 2002;
  • 2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-128[DOI][PubMed]
  • 3. Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, et al. Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One. 2012; 7(2)[DOI][PubMed]
  • 4. Nabipour I, Amiri M, Imami SR, Jahfari SM, Shafeiae E, Nosrati A, et al. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. Int J Cardiol. 2007; 118(1): 48-53[DOI][PubMed]
  • 5. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007; 27(12): 2729-35[DOI][PubMed]
  • 6. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009; 32(4): 741-50[DOI][PubMed]
  • 7. Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Atherosclerosis. 2014; 236(1): 7-17[DOI][PubMed]
  • 8. Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DJ. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil. 2009; 16(1): 16-20[DOI][PubMed]
  • 9. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25): 3143-421[PubMed]
  • 10. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R. Acc/aha guideline on the assessment of cardiovascular risk: A report of the american college of cardiology/american heart association task force on practice guidelines. J American College Cardiol. 2013; 63: 25
  • 11. Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 2012; 32(6): 945-50[DOI][PubMed]
  • 12. Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, et al. Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study. Arch Iran Med. 2014; 17(11): 750-4[PubMed]
  • 13. D'Agostino RS, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6): 743-53[DOI][PubMed]
  • 14. Gundberg CM, Looker AC, Nieman SD, Calvo MS. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone. 2002; 31(6): 703-8[PubMed]
  • 15. Ford I, Mooijaart SP, Lloyd S, Murray HM, Westendorp RG, de Craen AJ, et al. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol. 2011; 40(6): 1530-8[DOI][PubMed]
  • 16. McLean AJ, Cogger VC, Chong GC, Warren A, Markus AM, Dahlstrom JE, et al. Age-related pseudocapillarization of the human liver. J Pathol. 2003; 200(1): 112-7[DOI][PubMed]
  • 17. Schmucker DL. Aging and the liver: an update. J Gerontol A Biol Sci Med Sci. 1998; 53(5)-20[PubMed]
  • 18. Lankarani KB, Afshari R. Alcohol consumption in Iran. Lancet. 2014; 384(9958): 1927-8[DOI][PubMed]
  • 19. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342[DOI][PubMed]
  • 20. Bagnardi V, Zatonski W, Scotti L, La Vecchia C, Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health. 2008; 62(7): 615-9[DOI][PubMed]
  • 21. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004; 38(5): 613-9[DOI][PubMed]
  • 22. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000; 95(10): 1505-23[PubMed]
  • 23. Emberson JR, Bennett DA. Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both? Vasc Health Risk Manag. 2006; 2(3): 239-49[PubMed]
  • 24. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003; 289(5): 579-88[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments